Company Profiles

driven by the PitchBook Platform

Althia

Althia
2007 FOUNDED
M&A STATUS
Merger of Eq. LATEST DEAL TYPE
Description

Operator of a biomedical platform intended to offer specialized cancer drug. The company's biomedical platform focuses on personalized predictive oncology, enabling physicians treat their patients with personalized treatments for cancer and precancerous conditions.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Atrys Health
Primary Office
  • c/ Provença 392 Planta Baja
  • 08025 Barcelona
  • Spain

+34 902 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Althia’s full profile, request a free trial.

Althia Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger of Equals 09-Feb-2016 00.000 Completed Startup
1. Early Stage VC 04-Nov-2012 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Althia Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CECU Inversiones Corporation Minority 000 0000 000000 0
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0
Reiman Inversiones Corporation Minority 000 0000 000000 0

Althia Executive Team (11)

Name Title Board
Seat
Contact
Info
Isabel Lozano Chief Executive Officer
Santiago de Torres President
Anna Colomer Ph.D Diagnosis Area Director
Pedro Salord Director, Finance
Alicia Domingo Director, Hematology

2 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

Althia Board Members (1)

Name Representing Role Since Contact
Info
Carlos Cordón-Cardo Ph.D Althia Co-Founder & Scientific Vice Chairman 000 0000